GB1430223A - Anti-inflammatory composition comprising steroids - Google Patents
Anti-inflammatory composition comprising steroidsInfo
- Publication number
- GB1430223A GB1430223A GB4453174A GB4453174A GB1430223A GB 1430223 A GB1430223 A GB 1430223A GB 4453174 A GB4453174 A GB 4453174A GB 4453174 A GB4453174 A GB 4453174A GB 1430223 A GB1430223 A GB 1430223A
- Authority
- GB
- United Kingdom
- Prior art keywords
- steroids
- oct
- inflammatory composition
- circulin
- chloroxine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 150000003431 steroids Chemical class 0.000 title abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
- YKSVGLFNJPQDJE-YDMQLZBCSA-N (19E,21E,23E,25E,27E,29E,31E)-33-[(2R,3S,4R,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-17-[7-(4-aminophenyl)-5-hydroxy-4-methyl-7-oxoheptan-2-yl]-1,3,5,7,37-pentahydroxy-18-methyl-9,13,15-trioxo-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid Chemical compound CC(CC(C)C1OC(=O)CC(=O)CCCC(=O)CC(O)CC(O)CC(O)CC2(O)CC(O)C(C(CC(O[C@@H]3O[C@H](C)[C@@H](O)[C@@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\C1C)O2)C(O)=O)C(O)CC(=O)C1=CC=C(N)C=C1 YKSVGLFNJPQDJE-YDMQLZBCSA-N 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 abstract 1
- 229960004348 candicidin Drugs 0.000 abstract 1
- WDFKMLRRRCGAKS-UHFFFAOYSA-N chloroxine Chemical compound C1=CN=C2C(O)=C(Cl)C=C(Cl)C2=C1 WDFKMLRRRCGAKS-UHFFFAOYSA-N 0.000 abstract 1
- 229960004736 chloroxine Drugs 0.000 abstract 1
- YLHJFOAQDDQFIU-UHFFFAOYSA-N circulin Chemical compound CCC(C)C1NC(=O)C(CC(C)C)NC(=O)C(CCN)NC(=O)C(NC(=O)C(CCN)NC(=O)C(NC(=O)C(CCN)NC=O)C(C)O)CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC1=O YLHJFOAQDDQFIU-UHFFFAOYSA-N 0.000 abstract 1
- 108010002696 circulin Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
- 239000006210 lotion Substances 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 239000006072 paste Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 229930002330 retinoic acid Natural products 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- 229960001727 tretinoin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40942773A | 1973-10-25 | 1973-10-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1430223A true GB1430223A (en) | 1976-03-31 |
Family
ID=23620445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB4453174A Expired GB1430223A (en) | 1973-10-25 | 1974-10-09 | Anti-inflammatory composition comprising steroids |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE821496R (enrdf_load_stackoverflow) |
| FR (1) | FR2248846B2 (enrdf_load_stackoverflow) |
| GB (1) | GB1430223A (enrdf_load_stackoverflow) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826871A (en) * | 1985-03-13 | 1989-05-02 | Gressel Philip D | Topical ophthalmic compositions containing one or more retinoids |
| US4966773A (en) * | 1986-11-25 | 1990-10-30 | Alcon Laboratories, Inc. | Topical ophthalmic compositions containing microfine retinoid particles |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2365992C3 (de) * | 1972-03-09 | 1982-05-19 | The Upjohn Co., 49001 Kalamazoo, Mich. | 6α-Fluor-17,21-dihydroxy-16β-methylpregna-4,9(11)-dien-3,20-dion-17,21-diacetat und Verfahren zu dessen Herstellung |
-
1974
- 1974-10-09 GB GB4453174A patent/GB1430223A/en not_active Expired
- 1974-10-24 FR FR7435766A patent/FR2248846B2/fr not_active Expired
- 1974-10-25 BE BE149893A patent/BE821496R/xx not_active IP Right Cessation
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826871A (en) * | 1985-03-13 | 1989-05-02 | Gressel Philip D | Topical ophthalmic compositions containing one or more retinoids |
| US4966773A (en) * | 1986-11-25 | 1990-10-30 | Alcon Laboratories, Inc. | Topical ophthalmic compositions containing microfine retinoid particles |
Also Published As
| Publication number | Publication date |
|---|---|
| BE821496R (fr) | 1975-04-25 |
| FR2248846B2 (enrdf_load_stackoverflow) | 1982-07-09 |
| FR2248846A2 (enrdf_load_stackoverflow) | 1975-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE103813T1 (de) | Topische metronidazol-formulationen und deren verwendung als arzneimittel. | |
| JO1250B1 (en) | New pharmaceutical preparations | |
| DE3687341D1 (de) | Hautwirksame pharmaka mit liposomen als wirkstofftraeger. | |
| ZA874635B (en) | Novel anti-inflammatory agents,pharmaceutical compositions and methods for reducing inflammation | |
| IE39957B1 (en) | Steroid formulation | |
| ES2038643T3 (es) | Procedimiento para la obtencion de una composicion farmaceutica topica. | |
| GB1464388A (en) | Preparations containing microencapsulated substances and process | |
| GB1261348A (en) | Treatment of hair and scalp and compositions therefor | |
| GB1472308A (en) | Steroidal topical cream base | |
| GB1503388A (en) | Pharmaceutically active complexes and pharmaceutical compositions containing them | |
| AU3435189A (en) | Topically applied gold organic complex | |
| GB1191965A (en) | Betamethasone 17-Benzoate | |
| IE41287L (en) | Steroid pharmaceutical composition | |
| GB1291205A (en) | A novel pregnane derivative, processes for its preparation, and compositions incorporating it | |
| GB1430223A (en) | Anti-inflammatory composition comprising steroids | |
| IT8605115A0 (it) | Sistema di confezionamento e di impiego, senza assuefazione, diprodotti per applicazione topica sotto forma di emulsioni, creme, unguenti, paste, pomate, geli, lipogeli e simili. | |
| EP0249193A3 (en) | Vehicle for topical application of pharmaceuticals | |
| GB1487543A (en) | Dermatological composition | |
| IE810891L (en) | Topical formulation | |
| GB1287602A (en) | 4,6-DICHLORO-Delta<4.6>-OESTRADIENES | |
| GB1314926A (en) | Urea-derivatives | |
| GB1460163A (en) | Purification of 6,7-methylene steroid lactones | |
| IE34609B1 (en) | Antineoplastic therapeutic compositions | |
| GB1416839A (en) | 17beta-hydroxy-16,16-dimethylestr-4-en-3-one | |
| GB1199362A (en) | New Steroid Orthoesters and Process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed |